NCT02473120View on ClinicalTrials.gov

Study of ESR1 Mutations in Metastatic Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2019

Study Completion Date

October 31, 2019

Conditions
Metastatic Breast Cancer
Interventions
BIOLOGICAL

Determination of ESR1 mutations

Blood sample prelevement. Plasma issued from patient with metastatic breast cancer will be analysed at progression by Digital PCR to detect ESR1 mutations

Trial Locations (1)

76038

Centre Henri Becquerel, Rouen

All Listed Sponsors
lead

Centre Henri Becquerel

OTHER

NCT02473120 - Study of ESR1 Mutations in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter